Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 1
1992 2
1993 1
1995 1
1999 1
2000 1
2002 1
2004 2
2006 1
2010 1
2011 1
2012 1
2013 1
2015 1
2017 1
2018 2
2020 2
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Ampulla of Vater Neuroendocrine Tumor"
Page 1
Endoscopic Resection of Ampullary Neuroendocrine Tumor.
Fukasawa H, Tounou S, Nabetani M, Michida T. Fukasawa H, et al. Intern Med. 2017;56(5):499-503. doi: 10.2169/internalmedicine.56.7520. Epub 2017 Mar 1. Intern Med. 2017. PMID: 28250294 Free PMC article.
We report the case of a 57-year-old man with a 1.0-cm grade 1 neuroendocrine tumor (G1 NET) of the ampulla of Vater (ampullary NET) who underwent endoscopic snare papillectomy. ...In two years of follow-up, no local recurrence or metastasis occu …
We report the case of a 57-year-old man with a 1.0-cm grade 1 neuroendocrine tumor (G1 NET) of the ampulla of …
Multimodal treatment of neuroendocrine tumors of the pancreas and the ampulla of Vater.
Mantke R, Manger T, Schulz HU, Ridwelski K, Pross M, Günther T, Lippert H. Mantke R, et al. Dig Surg. 1999;16(2):145-51. doi: 10.1159/000018708. Dig Surg. 1999. PMID: 10207242
Neuroendocrine tumors are not seen frequently. They are most commonly located in the small bowel including the vermiform appendix. ...In this article, we report on 6 patients suffering from primary neuroendocrine tumors of the pancreas or the ampull …
Neuroendocrine tumors are not seen frequently. They are most commonly located in the small bowel including the vermiform appen …
Interventional endoscopy, neoadjuvant therapy and the gastroenterologist.
Snady H. Snady H. Hematol Oncol Clin North Am. 2002 Feb;16(1):53-79. doi: 10.1016/s0889-8588(01)00010-7. Hematol Oncol Clin North Am. 2002. PMID: 12063829 Review.
Relief of biliary obstruction allows improvement in liver function and more time to evaluate tumor stage accurately to determine initial treatment (see Fig. 1). ...Tumors can be resected after neoadjuvant chemoradiotherapy. For chronic pain or gastric outlet obstruc …
Relief of biliary obstruction allows improvement in liver function and more time to evaluate tumor stage accurately to determine init …
The clinical profiles, management, and prognostic factors of biliary mixed neuroendocrine nonneuroendocrine neoplasms: A systematic review of the literature.
Wen LJ, Chen JH, Xu HJ, Yu Q, Deng Y, Liu K. Wen LJ, et al. Medicine (Baltimore). 2020 Dec 11;99(50):e23271. doi: 10.1097/MD.0000000000023271. Medicine (Baltimore). 2020. PMID: 33327249 Free PMC article.
BACKGROUND: Mixed neuroendocrine nonneuroendocrine neoplasms (MiNENs) originating from the biliary system (gallbladder, biliary tract, or ampulla of Vater) are extremely rare and have not been discussed in detail or systematically. ...Log-rank tests we …
BACKGROUND: Mixed neuroendocrine nonneuroendocrine neoplasms (MiNENs) originating from the biliary system (gallbladder, biliary tract …
Totally laparoscopic versus open pancreaticoduodenectomy: A propensity score matching analysis of short-term outcomes.
Mazzola M, Giani A, Crippa J, Morini L, Zironda A, Bertoglio CL, De Martini P, Magistro C, Ferrari G. Mazzola M, et al. Eur J Surg Oncol. 2021 Mar;47(3 Pt B):674-680. doi: 10.1016/j.ejso.2020.10.036. Epub 2020 Nov 5. Eur J Surg Oncol. 2021. PMID: 33176959
INTRODUCTION: Laparoscopic pancreaticoduodenectomy (LPD) is a demanding operation that has not yet gained popularity. Safety, feasibility, and clinical advantages of LPD in comparison with open pancreaticoduodenectomy (OPD) have not been clearly demonstrated. ...
INTRODUCTION: Laparoscopic pancreaticoduodenectomy (LPD) is a demanding operation that has not yet gained popularity. Safety, feasibility, a …
Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors.
Adham M, Singhirunnusorn J. Adham M, et al. Eur J Surg Oncol. 2012 Apr;38(4):340-5. doi: 10.1016/j.ejso.2011.12.015. Epub 2012 Jan 20. Eur J Surg Oncol. 2012. PMID: 22264964 Clinical Trial.
Pathology revealed an adenocarcinoma of the pancreatic duct, distal bile duct, periampullary and neuroendocrine carcinoma. Mesopancreas was invaded by cancer in 12 cases, of these, 3 had invaded margins and 7 had a margin less than 1 mm. ...
Pathology revealed an adenocarcinoma of the pancreatic duct, distal bile duct, periampullary and neuroendocrine carcinoma. Mesopancre …
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.
Iwasa S, Morizane C, Okusaka T, Ueno H, Ikeda M, Kondo S, Tanaka T, Nakachi K, Mitsunaga S, Kojima Y, Hagihara A, Hiraoka N. Iwasa S, et al. Jpn J Clin Oncol. 2010 Apr;40(4):313-8. doi: 10.1093/jjco/hyp173. Epub 2010 Jan 4. Jpn J Clin Oncol. 2010. PMID: 20047862
METHODS: We reviewed the cases in our database from October 1995 to January 2009 and retrospectively examined the clinical data of patients, with unresectable or recurrent poorly differentiated neuroendocrine carcinoma arising from the hepatobiliary tract and pancre …
METHODS: We reviewed the cases in our database from October 1995 to January 2009 and retrospectively examined the clinical data of pa …
Factors predictive of malignancy and endoscopic resectability in ampullary neoplasia.
Kahaleh M, Shami VM, Brock A, Conaway MR, Yoshida C, Moskaluk CA, Adams RB, Tokar J, Yeaton P. Kahaleh M, et al. Am J Gastroenterol. 2004 Dec;99(12):2335-9. doi: 10.1111/j.1572-0241.2004.40391.x. Am J Gastroenterol. 2004. PMID: 15571579
Data elements for analysis included EUS findings, lesion lifting with submucosal injection, age, gender, tumor size, and endoscopic intervention. Analyses were performed to determine the ability to predict malignancy and the ability to extirpate benign lesions. ...Final di …
Data elements for analysis included EUS findings, lesion lifting with submucosal injection, age, gender, tumor size, and endoscopic i …
22 results